跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,079 条关于
“lysine H3K36”
全部
5,079
临床试验
4,531
药物
136
机构
12
资讯
400
4年前
K36 Therapeutics Receives FDA Clearance for First-in-Class Multiple Myeloma Drug KTX-1001
去年
Salarius Pharmaceuticals' Seclidemstat Gains Validation as LSD1 Inhibitor in New Studies While Phase 1/2 Trial Advances
去年
NIH Grants Exclusive License to Sangam Lifesciences for Novel Cancer Drug Delivery Platform
去年
Lighthouse Pharmaceuticals Secures $49.2 Million NIH Grant for Novel Alzheimer's Disease Treatment Targeting Bacterial Infection
去年
Non-Histone Lactylation Emerges as Key Regulator in Cancer Progression and Therapeutic Target
去年
DEP-SN38 Dendrimer Nanoparticle Shows Promise in Advanced Solid Tumors with Reduced Toxicity Profile
去年
FDA Approves Revumenib (Revuforj) as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation
2年前
Merck's Bomedemstat Shows Promise as Irreversible LSD1 Inhibitor for MPNs
2个月前
The Lactate–Lactylation Axis in Tumor Radioresistance: From Metabolic Adaptation to Therapeutic Targeting
去年
FDA Approves Revuforj (revumenib) for Relapsed/Refractory Acute Leukemia with KMT2A Translocation
第 1 页,共 40 页
上一页
下一页